Lucid Diagnostics Inc. Income Statement
LUCD|4 years of annual SEC 10-K data (FY2021-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$2M
FY2024
Gross Profit
N/A
FY2024
Operating Income
-$48M
FY2024
Net Income
-$53M
FY2024
Lucid Diagnostics Inc. reported $2M in revenue and $53M in net loss for FY2024. Revenue has grown at a 69.3% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $2.4M | $377.0K | $500.0K | $500.0K |
| Cost of Revenue | - | - | $100.0M | $585.0K |
| Gross Profit | - | - | $500.0K | -$85.0K |
| SG&A Expense | $19.3M | $24.0M | $21.0K | $7.0K |
| R&D Expense | $7.3M | $11.3M | $9.3M | $5.4M |
| Operating Income | -$48.5M | -$56.3M | -$27.4M | -$8.3M |
| Interest Expense | $416.0K | $8.0K | $659.0K | $659.0K |
| Net Income | -$52.7M | -$56.2M | -$28.1M | -$8.3M |
| EPS (Basic) | -$1.26 | -$1.55 | -$1.51 | - |
| EPS (Diluted) | -$1.26 | -$1.55 | - | -$0.59 |
| Shares Outstanding | 42.3M | 40.5M | 34.9M | 14.1M |
| Gross Margin | - | - | 100.0% | -17.0% |
| Operating Margin | -1996.8% | -14920.7% | -5483.8% | -1656.0% |
| Profit Margin | -2169.1% | -14899.5% | -5615.6% | -1656.0% |